3-aminobenzamide has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SK | 1 |
| Galán, M | 1 |
| Kassan, M | 1 |
| Partyka, M | 1 |
| Trebak, M | 1 |
| Matrougui, K | 1 |
| Szabó, C | 1 |
| Biser, A | 1 |
| Benko, R | 1 |
| Böttinger, E | 1 |
| Suszták, K | 1 |
2 other studies available for 3-aminobenzamide and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Poly(ADP-ribose) polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus.
Topics: Animals; Benzimidazoles; Blood Glucose; Blood Pressure Determination; Blotting, Western; Body Weight | 2012 |
Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice.
Topics: Animals; Apoptosis; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; | 2006 |